HT941024N0017 NOI to Sole Source.pdf

Notice of Intent to Sole Source

HT941024N0017

THIS IS A NOTICE OF INTENT TO AWARD A SOLE SOURCE SUPPLY CONTRACT

AND IS NOT A REQUEST FOR COMPETITIVE QUOTES. The Defense Health Agency intends to negotiate on a sole source basis IAW FAR 13.501(a), Only One Responsible Source.

The proposed source is Roche Diagnostics Corporation, 9915 Hague Rd, Indianapolis, Indiana, 46256-1025.

The requirement is for a contract for two (2) analyzers, laboratory, clinical chemistry/immunoassay [20- 821], reagents, quality control, maintenance, and consumables for Naval Health Clinic (NHC) Hawaii. One (1) clinical chemistry/immunoassay analyzer shall be for Branch Health Clinic (BHC) Makalapa, and one (1) clinical chemistry/immunoassay analyzer shall be for BHC Kaneohe Bay. The contracted analyzers shall be capable of performing general chemistry, special chemistry, immunoassay, and screening for electrolytes, therapeutic drugs, drugs of abuse, toxicology, diabetes, hepatic diseases, thyroid diseases, cardiac diseases, anemia panels, and autoimmune diseases, as defined below. The contracted analyzers for each clinic shall be capable of performing the tests listed below at the yearly indicated test volume. The contracted analyzers for BHC Makalapa and BHC Kaneohe Bay shall have the same test platform to ensure accuracy of results between clinics. The contractor shall be capable of 24 hour response time. The contractor shall be available for telephone troubleshooting consultation 24 hours a day, 7 days a week, 365 days per year, except on Federal holidays. The contract shall include operator training.

BHC Makalapa Requirements:

The contracted analyzer shall be capable of completing a minimum of 1,000 tests per hour. The contracted analyzer shall fit within the following dimensions: 52 inches (H) x 122 inches (W) x 52 inches (D). The contracted analyzer shall perform the annual estimated test volume as indicated below. The contracted analyzer shall also include FT3, FT4, and HCG, B at no cost, as needed.

ANNUAL ESTIMATED TEST VOLUME (REPORTABLE) – BHC MAKALAPA

TEST QTY TEST QTY TEST QTY

ALBUMIN

CREATININE

PHOSPHORUS

ALKP

CREATINE KINASE

POTASSIUM

ALT

10080

GGT

SODIUM

AST 10080 GLUCOSE 25220 T3 1720

BICARBONATE

T4

BILIRUBIN, DIRECT

HCG

TOTAL PROTEIN

BILIRUBIN, TOTAL

10600

HDL

12160

TRIGLYCERIDES

12260

CALCIUM

HBA1c

TSH

CHLORIDE 3600 LDL 12420 UREA/BUN 9120

CHOLESTEROL, TOTAL 12240 MAGNESIUM 1896 URIC ACID 4200

BHC Kaneohe Bay Requirements:

The contracted analyzer shall be capable of completing a minimum of 375 tests per hour. The contracted analyzer shall fit within the following dimensions: 50 inches (H) x 100 inches (W) x 34 inches (D). The contracted analyzer shall perform the annual estimated test volume as indicated below. The contracted analyzer shall also include FT3, FT4, and HCG, B at no cost, as needed.

ANNUAL ESTIMATED TEST VOLUME (REPORTABLE) – BHC KANEOHE BAY

TEST QTY TEST QTY TEST QTY

ALBUMIN

CHOLESTEROL, TOTAL

PHOSPHORUS

ALKP

CREATININE

T3

ALT

CREATINE KINASE

T4

AST 4210 GGT 1240 TRIGLYCERIDES 5123

BICARBONATE

GLUCOSE

12240

TSH

BILIRUBIN, DIRECT

HDL

UREA/BUN

BILIRUBIN, TOTAL 4100 HBA1c 1798 URIC ACID 2240

CALCIUM

LDL

HCG

1. Equipment

a. The analyzers shall utilize liquid, ready-to-use reagents and shall not require the manipulation/reconstitution of reagents for testing

b. The analyzers shall not require major facility changes beyond electrical.

c. The analyzers shall be capable of adding new third party tests.

d. The analyzers shall be capable of utilizing the following sample types without the need for the following pre-treatments: serum, plasma, urine, and cerebrospinal fluid (CSF).

e. The analyzers shall be capable of automatic quality control (QC) and automatic calibration

f. The analyzers shall be capable of pre-calibrating and storing at least two (2) lots onboard the unit.

g. The analyzers shall have sufficient onboard storage to accommodate daily workload as outlined above.

h. The analyzers shall complete STAT (urgent) requests in, at most, 60 minutes.

i. The analyzers shall be capable of auto-dilution.

j. The analyzers shall be capable of utilizing sample tube bar codes for accurate sample identification.

k. The analyzers shall be capable of interfacing with the Composite Health Care System

(CHCS) laboratory information management system.

l. The analyzers shall include programmable panels to accommodate in-house needs.

m. The analyzers shall be capable of starting up without priming or washes.

n. The analyzers shall be capable of external data storage in compliance with

Navy/Department of Defense (DoD) Information Assurance (IA) regulations.

o. The analyzers shall include an uninterruptible power supply (UPS) that is compatible with all system components, is capable of conditioning the power to the system, and allows the system a minimum of 30 minutes run time in case of a power outage.

p. The power requirement is 250 VAC, 60 Hz, 30 Amps, single phase.

Periods of Performance Base: 01 January 2024 - 30 June 2024 OPT1: 01 July 2024 - 31 December 2024

There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 334516. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government.

A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Nicole Ventinilla at nicole.e.ventinilla.civ@health.mil. Closing date for challenges is no later than 0800 PST on 18 December 2023. No phone calls will be accepted.

Renier Valdez Contracting Officer mailto:nicole.e.ventinilla.civ@health.mil